Loxo Oncology
Utility Patent Applications

Last updated:

List of all Loxo Oncology patents 17 in total

Status Patent
Application
Utility: FORMULATIONS OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: METHODS OF DIAGNOSING AND TREATING CANCER External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: FORMULATIONS OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: COMPOUNDS USEFUL AS KINASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: SPRAY-DRIED DISPERSIONS, FORMULATIONS, AND POLYMORPHS OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-(1,1,1-TR- IFLUOROPROPAN-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE External link
Filling date: 6 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: POINT MUTATIONS IN TRK INHIBITOR-RESISTANT CANCER AND METHODS RELATING TO THE SAME External link
Filling date: 6 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: COMPOUNDS USEFUL AS KINASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: FORMULATIONS OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE External link
Filling date: 6 Sep 2025 Issue date: 18 Mar 2021
Application
Utility: TREATMENT OF TRK-ASSOCIATED CANCERS External link
Filling date: 6 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRI- MIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: COMPOUNDS USEFUL AS KINASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: METHODS OF TREATING PEDIATRIC CANCERS External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Jul 2020
Application
Utility: FORMULATIONS OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE External link
Filling date: 6 Sep 2025 Issue date: 29 Aug 2019
Application
Utility: FORMULATIONS OF A MACROCYCLIC TRK KINASE INHIBITOR External link
Filling date: 6 Sep 2025 Issue date: 15 Aug 2019

Showing 1 to 17 of 17 patents.